Mark Anderson Selected Research

Immune Checkpoint Inhibitors

2/2023	Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced Hypophysitis.
10/2020	Breaking β Cell Tolerance After 100 Years of Life: Intratumoral Immunotherapy-Induced Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Anderson Research Topics

Disease

26	Infections 09/2023 - 12/2012
18	Neoplasms (Cancer) 05/2024 - 10/2007
17	COVID-19 01/2023 - 01/2021
7	Chronic Hepatitis B 04/2024 - 01/2021
7	Hepatitis B 09/2023 - 01/2021
6	Myocardial Infarction 01/2024 - 09/2010
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 01/2018
4	Cardiogenic Shock 01/2024 - 09/2010
4	Malaria 11/2022 - 01/2019
3	Shock 01/2024 - 05/2005
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 11/2014
3	Hemorrhage 01/2022 - 01/2014
3	Coinfection 01/2022 - 01/2021
3	Sepsis (Septicemia) 01/2017 - 02/2013
3	Conjunctivitis 02/2013 - 12/2011
3	Seizures (Absence Seizure) 01/2013 - 12/2010
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 05/2024 - 03/2020
2	Virus Diseases (Viral Diseases) 12/2023 - 01/2022
2	Inflammation (Inflammations) 04/2023 - 01/2016
2	Melanoma (Melanoma, Malignant) 02/2023 - 10/2020
2	Edema (Dropsy) 01/2023 - 09/2006
2	Pain (Aches) 03/2022 - 01/2014
2	Cardiomyopathies (Cardiomyopathy) 07/2021 - 01/2020
2	Myocarditis (Carditis) 07/2021 - 01/2020
2	Hyperthermia 01/2019 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 12/2018 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 06/2015 - 09/2010
2	Embryonal Carcinoma 04/2013 - 11/2012
2	Adenocarcinoma 10/2012 - 10/2007
2	Wounds and Injuries (Trauma) 01/2012 - 11/2008
2	Asthma (Bronchial Asthma) 10/2010 - 02/2009
1	Rupture 03/2024
1	isovaleric Acidemia 03/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Prostatic Neoplasms (Prostate Cancer) 01/2024
1	Multiple Sclerosis 06/2023
1	Pathologic Processes 06/2023
1	Disease Progression 05/2023
1	Fibrosis (Cirrhosis) 04/2023

Drug/Important Bio-Agent (IBA)

13	Immunoglobulin G (IgG)IBA 06/2023 - 01/2021
10	AntibodiesIBA 06/2023 - 05/2014
8	AutoantibodiesIBA 05/2024 - 01/2018
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2012
8	VaccinesIBA 12/2023 - 02/2009
7	AntigensIBA 09/2023 - 01/2021
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 01/2021
6	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
6	NVC-422IBA 05/2013 - 08/2011
5	Hepatitis B e AntigensIBA 04/2024 - 11/2021
5	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 10/2009
5	Proteins (Proteins, Gene)FDA Link 09/2023 - 02/2014
5	Nucleic AcidsIBA 09/2023 - 01/2021
4	InterferonsIBA 04/2024 - 01/2021
4	BNT162 VaccineIBA 01/2023 - 01/2021
4	Insulin (Novolin)FDA Link 10/2020 - 01/2018
3	Antiviral Agents (Antivirals)IBA 04/2024 - 10/2021
3	PolymersIBA 09/2023 - 11/2021
2	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 09/2023 - 11/2021
2	Tenofovir (Viread)FDA Link 09/2023 - 11/2021
2	Circular DNAIBA 09/2023 - 01/2022
2	N-(2-cyanoethylene)urea (BA 1)IBA 06/2023 - 11/2022
2	Immune Checkpoint InhibitorsIBA 02/2023 - 10/2020
2	Surface Antigens (Surface Antigen)IBA 01/2023 - 10/2021
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2022
2	pgRNAIBA 01/2023 - 01/2021
2	COVID-19 VaccinesIBA 11/2022 - 01/2022
2	Neutralizing AntibodiesIBA 11/2022 - 10/2022
2	Immunoglobulin M (IgM)IBA 02/2022 - 10/2021
2	Alanine Transaminase (SGPT)IBA 01/2022 - 11/2021
2	Antigen-Antibody Complex (Immune Complex)IBA 11/2021 - 01/2021
2	epidermal growth factor receptor VIIIIBA 04/2021 - 11/2014
2	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 01/2018
2	C-PeptideIBA 12/2018 - 01/2018
2	CytokinesIBA 01/2017 - 01/2017
2	Anticonvulsants (Antiepileptic Drugs)IBA 06/2015 - 09/2010
2	stage-specific embryonic antigen-4IBA 04/2013 - 11/2012
2	NitrogenIBA 01/2007 - 05/2005
2	Soaps (Soap)IBA 01/2007 - 05/2005
1	Imatinib Mesylate (Gleevec)FDA Link 05/2024
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2024
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 05/2024
1	pivaloylcarnitineIBA 03/2024
1	Denosumab FDA Link 01/2024
1	Hepatitis B Core AntigensIBA 09/2023
1	Glial Fibrillary Acidic ProteinIBA 06/2023

Therapy/Procedure

20	Therapeutics 04/2024 - 10/2009
4	Percutaneous Coronary Intervention 01/2024 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2023 - 10/2009
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2021 - 09/2006
3	Critical Care (Surgical Intensive Care) 01/2016 - 01/2014
2	Euthanasia (Mercy Killing) 03/2022 - 01/2016
2	Peritoneal Dialysis 01/2022 - 01/2021
2	Renal Dialysis (Hemodialysis) 01/2022 - 01/2021
2	Aftercare (After-Treatment) 04/2021 - 10/2007
2	Immunotherapy 10/2020 - 03/2020
2	Heart-Assist Devices 12/2018 - 09/2010
2	Radiofrequency Ablation 01/2018 - 09/2006
2	Length of Stay 01/2018 - 01/2014
2	Lasers (Laser) 01/2007 - 05/2005
1	Transcatheter Aortic Valve Replacement 03/2024